Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
Active, not recruiting · NCT06152237 · Registry updated 2025-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Rett syndrome, X-linked disease, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-10-15 | NCT06152237 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Taysha Gene Therapies, Inc. | 4 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust | London | United Kingdom | 1 |
| CHU Ste-Justine | Montreal | Canada | 5 |
| Gillette Children's Specialty Healthcare | Saint Paul | United States | 11 |
| Rush University Medical Center & Children's Hospital | Chicago | United States | 1 |
| Washington University, St. Louis | St Louis | United States | 10 |